Lyme disease vaccine

Study

Clinical Study on Lyme Disease: Seeking Volunteers (Ages 18-70)

The Situation in Québec

The presence of ticks is increasing in Quebec, leading to a rise in Lyme disease diagnoses. This bacterial infection can, in some patients, lead to complications affecting the joints, heart, or nervous system if it is not treated promptly.

The Study's Objective

Currently, there is no licensed vaccine to prevent this disease in humans. The Diex Research team is preparing a clinical study to evaluate an investigational vaccine designed for the prevention of Lyme disease.

What Participating in this Study Means:

- Health Assessment: You will receive rigorous medical supervision from our healthcare professionals throughout the study.

- Contribution to Science: Your participation helps advance knowledge on the prevention of Lyme disease.

- No cost: The follow-ups and examinations required by the study protocol are offered free of charge to the participant.

- Compensation: Financial compensation is provided to cover your time and travel expenses.

Eligibility and Volunteering

Participation in this research is entirely voluntary. You may withdraw from the study at any time, without providing a reason.

To be eligible, you must:

  1. Be between 18 and 70 years old.
  2. Meet specific eligibility criteria, which will be assessed during an initial contact.

Would you like more information?

Our recruitment team is available to answer your questions and discuss the eligibility process with you. Please take a few minutes to complete the form.

I want to apply to this clinical study

Participate in the study of Joliette Participate in the study of Québec Participate in the study of Sherbrooke (West) Participate in the study of Victoriaville

For more information, contact us at
579 841-0571 (Joliette), 581 477-3439 (Québec), 819 346-2887 (Sherbrooke (West)), 819 260-1172 (Victoriaville)
or at 1-844-739-3439 (toll free), or fill the online form.

The study process in pictures

Explanation

Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.

Meeting

Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.

Decision

Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.

Tests

Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.

Departure

Step 5 | If you are eligible, you may then begin a clinical study with us.